

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | omega-hydroxylase P450 pathway (GO:0097267) | 9.55366742 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.55987521 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.55987521 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.22240490 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.22240490 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.79094490 |
| 7 | drug metabolic process (GO:0017144) | 6.53401441 |
| 8 | oxidative demethylation (GO:0070989) | 6.34645076 |
| 9 | ethanol metabolic process (GO:0006067) | 6.26689343 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.26110504 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.09159082 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.09159082 |
| 13 | tryptophan catabolic process (GO:0006569) | 6.09159082 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.97097626 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.93783057 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.74323201 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.74161724 |
| 18 | urea metabolic process (GO:0019627) | 5.70359915 |
| 19 | urea cycle (GO:0000050) | 5.70359915 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.68860708 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.54833050 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.46442662 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.35340948 |
| 24 | complement activation, alternative pathway (GO:0006957) | 5.31822116 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.30139249 |
| 26 | protein carboxylation (GO:0018214) | 5.30139249 |
| 27 | regulation of protein activation cascade (GO:2000257) | 5.28306895 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 5.27306794 |
| 29 | phenylpropanoid metabolic process (GO:0009698) | 5.27192657 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.24584994 |
| 31 | cysteine metabolic process (GO:0006534) | 5.23329293 |
| 32 | regulation of plasminogen activation (GO:0010755) | 5.18176550 |
| 33 | bile acid metabolic process (GO:0008206) | 5.07352985 |
| 34 | serine family amino acid catabolic process (GO:0009071) | 5.06130869 |
| 35 | regulation of complement activation (GO:0030449) | 4.95384942 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 4.93149453 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 4.91124640 |
| 38 | opsonization (GO:0008228) | 4.90682713 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.90011651 |
| 40 | homocysteine metabolic process (GO:0050667) | 4.84021170 |
| 41 | negative regulation of hemostasis (GO:1900047) | 4.83765855 |
| 42 | negative regulation of blood coagulation (GO:0030195) | 4.83765855 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.81796449 |
| 44 | S-adenosylmethionine metabolic process (GO:0046500) | 4.81641050 |
| 45 | reverse cholesterol transport (GO:0043691) | 4.80006950 |
| 46 | regulation of cholesterol esterification (GO:0010872) | 4.76189407 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 4.71649711 |
| 48 | macromolecular complex remodeling (GO:0034367) | 4.71649711 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.71649711 |
| 50 | lysine catabolic process (GO:0006554) | 4.70982013 |
| 51 | lysine metabolic process (GO:0006553) | 4.70982013 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 4.67772217 |
| 53 | alpha-amino acid catabolic process (GO:1901606) | 4.65122617 |
| 54 | regulation of humoral immune response (GO:0002920) | 4.61515543 |
| 55 | acylglycerol homeostasis (GO:0055090) | 4.61296174 |
| 56 | triglyceride homeostasis (GO:0070328) | 4.61296174 |
| 57 | acute-phase response (GO:0006953) | 4.50521254 |
| 58 | negative regulation of sterol transport (GO:0032372) | 4.49666840 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 4.49666840 |
| 60 | phospholipid efflux (GO:0033700) | 4.48109274 |
| 61 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.46837310 |
| 62 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.46837310 |
| 63 | negative regulation of protein activation cascade (GO:2000258) | 4.45173921 |
| 64 | cellular ketone body metabolic process (GO:0046950) | 4.43101092 |
| 65 | plasma lipoprotein particle clearance (GO:0034381) | 4.39145686 |
| 66 | coenzyme catabolic process (GO:0009109) | 4.38601828 |
| 67 | negative regulation of coagulation (GO:0050819) | 4.38406617 |
| 68 | glycine metabolic process (GO:0006544) | 4.34766542 |
| 69 | positive regulation of hemostasis (GO:1900048) | 4.34658111 |
| 70 | positive regulation of blood coagulation (GO:0030194) | 4.34658111 |
| 71 | negative regulation of wound healing (GO:0061045) | 4.33431310 |
| 72 | alkaloid metabolic process (GO:0009820) | 4.33176299 |
| 73 | bile acid and bile salt transport (GO:0015721) | 4.32165031 |
| 74 | indolalkylamine metabolic process (GO:0006586) | 4.31685701 |
| 75 | cellular amino acid catabolic process (GO:0009063) | 4.28271657 |
| 76 | imidazole-containing compound metabolic process (GO:0052803) | 4.26205281 |
| 77 | cellular glucuronidation (GO:0052695) | 4.24947612 |
| 78 | amine catabolic process (GO:0009310) | 4.21788282 |
| 79 | cellular biogenic amine catabolic process (GO:0042402) | 4.21788282 |
| 80 | glutamate metabolic process (GO:0006536) | 4.19617280 |
| 81 | cholesterol efflux (GO:0033344) | 4.18588512 |
| 82 | serine family amino acid metabolic process (GO:0009069) | 4.13244383 |
| 83 | ethanol oxidation (GO:0006069) | 4.06635690 |
| 84 | benzene-containing compound metabolic process (GO:0042537) | 4.05459266 |
| 85 | cellular modified amino acid catabolic process (GO:0042219) | 4.03338921 |
| 86 | arginine metabolic process (GO:0006525) | 4.03031759 |
| 87 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.98625205 |
| 88 | positive regulation of coagulation (GO:0050820) | 3.98151442 |
| 89 | fibrinolysis (GO:0042730) | 3.96775068 |
| 90 | drug catabolic process (GO:0042737) | 3.96222196 |
| 91 | plasma lipoprotein particle assembly (GO:0034377) | 3.95516065 |
| 92 | aldehyde catabolic process (GO:0046185) | 3.93830677 |
| 93 | serine family amino acid biosynthetic process (GO:0009070) | 3.92409146 |
| 94 | low-density lipoprotein particle remodeling (GO:0034374) | 3.90255236 |
| 95 | positive regulation of lipid catabolic process (GO:0050996) | 3.86579652 |
| 96 | ketone body metabolic process (GO:1902224) | 3.83437955 |
| 97 | blood coagulation, intrinsic pathway (GO:0007597) | 3.82607021 |
| 98 | acetyl-CoA metabolic process (GO:0006084) | 3.80983902 |
| 99 | cofactor catabolic process (GO:0051187) | 3.80324224 |
| 100 | regulation of bile acid biosynthetic process (GO:0070857) | 3.79149105 |
| 101 | carboxylic acid catabolic process (GO:0046395) | 3.77847357 |
| 102 | organic acid catabolic process (GO:0016054) | 3.77847357 |
| 103 | phospholipid homeostasis (GO:0055091) | 3.77490186 |
| 104 | glucuronate metabolic process (GO:0019585) | 3.77388108 |
| 105 | uronic acid metabolic process (GO:0006063) | 3.77388108 |
| 106 | negative regulation of lipase activity (GO:0060192) | 3.76947945 |
| 107 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.76755967 |
| 108 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.76755967 |
| 109 | negative regulation of complement activation (GO:0045916) | 3.76404025 |
| 110 | cholesterol homeostasis (GO:0042632) | 3.75338224 |
| 111 | complement activation, classical pathway (GO:0006958) | 3.71445692 |
| 112 | short-chain fatty acid metabolic process (GO:0046459) | 3.71249327 |
| 113 | cytolysis (GO:0019835) | 3.71110467 |
| 114 | complement activation (GO:0006956) | 3.69730606 |
| 115 | sterol homeostasis (GO:0055092) | 3.69163778 |
| 116 | protein activation cascade (GO:0072376) | 3.67857054 |
| 117 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.67638170 |
| 118 | flavonoid metabolic process (GO:0009812) | 3.67121101 |
| 119 | epoxygenase P450 pathway (GO:0019373) | 3.64824604 |
| 120 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.63478018 |
| 121 | xenobiotic metabolic process (GO:0006805) | 3.61583229 |
| 122 | hormone catabolic process (GO:0042447) | 3.61461637 |
| 123 | regulation of cholesterol homeostasis (GO:2000188) | 3.60708773 |
| 124 | plasma lipoprotein particle organization (GO:0071827) | 3.59854475 |
| 125 | exogenous drug catabolic process (GO:0042738) | 3.55677461 |
| 126 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.54102724 |
| 127 | response to mercury ion (GO:0046689) | 3.47604341 |
| 128 | intestinal cholesterol absorption (GO:0030299) | 3.45764998 |
| 129 | acute inflammatory response (GO:0002526) | 3.42191041 |
| 130 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.32334275 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.38358876 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.16323693 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.94282523 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.49731427 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.35927059 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.20946116 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.05613490 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.04696446 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.95385449 |
| 10 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09199089 |
| 11 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06248218 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9496444 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98533083 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.66160612 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61621974 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56607676 |
| 17 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.41277841 |
| 18 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40863973 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28651252 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19970671 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17965883 |
| 22 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.17830317 |
| 23 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.03731072 |
| 24 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.03647065 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.02792460 |
| 26 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.99028258 |
| 27 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98652177 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97462477 |
| 29 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.93492065 |
| 30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92662925 |
| 31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92466543 |
| 32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90059263 |
| 33 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.89462497 |
| 34 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.87693767 |
| 35 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85886641 |
| 36 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85336448 |
| 37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85320288 |
| 38 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.84712227 |
| 39 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.84674311 |
| 40 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.84246340 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83462907 |
| 42 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.83319686 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.81951790 |
| 44 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.80196390 |
| 45 | NFYA_21822215_ChIP-Seq_K562_Human | 0.79794739 |
| 46 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79598031 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79102822 |
| 48 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.76836601 |
| 49 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.75070247 |
| 50 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.74890107 |
| 51 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74080558 |
| 52 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73335271 |
| 53 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73326710 |
| 54 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72906286 |
| 55 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.71808749 |
| 56 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.71647137 |
| 57 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71496542 |
| 58 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.70693952 |
| 59 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.70287499 |
| 60 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69981860 |
| 61 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.69870409 |
| 62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.69147787 |
| 63 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68536781 |
| 64 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68385464 |
| 65 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.68231280 |
| 66 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.68203901 |
| 67 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.67852976 |
| 68 | NFYB_21822215_ChIP-Seq_K562_Human | 0.64745057 |
| 69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.64068731 |
| 70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63693763 |
| 71 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.63602443 |
| 72 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63489872 |
| 73 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63489872 |
| 74 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.62521554 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.62493761 |
| 76 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62219097 |
| 77 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62197521 |
| 78 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.62189821 |
| 79 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.61835530 |
| 80 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.61086423 |
| 81 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.60932870 |
| 82 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60780315 |
| 83 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59510081 |
| 84 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.59135943 |
| 85 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.58989926 |
| 86 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58866292 |
| 87 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.58287770 |
| 88 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.57692067 |
| 89 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.55890228 |
| 90 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.54633244 |
| 91 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54187670 |
| 92 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53655595 |
| 93 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.52897957 |
| 94 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.52842434 |
| 95 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52612384 |
| 96 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.52580926 |
| 97 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.52420412 |
| 98 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51834161 |
| 99 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51800090 |
| 100 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.51597109 |
| 101 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.51126044 |
| 102 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.51117435 |
| 103 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50838032 |
| 104 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.50677422 |
| 105 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50385684 |
| 106 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.50369875 |
| 107 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.49971148 |
| 108 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.49187632 |
| 109 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.49119632 |
| 110 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46987755 |
| 111 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.46423863 |
| 112 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46417354 |
| 113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.46015460 |
| 114 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.45997744 |
| 115 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45948177 |
| 116 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.43742228 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.43420157 |
| 118 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.42851403 |
| 119 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.42580569 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42543966 |
| 121 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41957581 |
| 122 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.41909330 |
| 123 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.41584023 |
| 124 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41568002 |
| 125 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41064266 |
| 126 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39879383 |
| 127 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38244023 |
| 128 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.38199729 |
| 129 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.37777645 |
| 130 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.37691191 |
| 131 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.36594522 |
| 132 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.36503246 |
| 133 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36030028 |
| 134 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.35385433 |
| 135 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.34471376 |
| 136 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.34089057 |
| 137 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.33958072 |
| 138 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.33755293 |
| 139 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.33679175 |
| 140 | NCOR_22424771_ChIP-Seq_293T_Human | 0.33205150 |
| 141 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.32755837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.27516910 |
| 2 | MP0005360_urolithiasis | 7.52971581 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.48636151 |
| 4 | MP0005365_abnormal_bile_salt | 6.17494034 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.20331737 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.08806539 |
| 7 | MP0003252_abnormal_bile_duct | 3.92449008 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.62054177 |
| 9 | MP0009840_abnormal_foam_cell | 3.22269242 |
| 10 | MP0005083_abnormal_biliary_tract | 3.05746881 |
| 11 | MP0005332_abnormal_amino_acid | 2.80429013 |
| 12 | MP0003195_calcinosis | 2.79161518 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.57589728 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.31414698 |
| 15 | * MP0000609_abnormal_liver_physiology | 2.16706505 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.14687078 |
| 17 | * MP0002118_abnormal_lipid_homeostasis | 2.12637387 |
| 18 | MP0003868_abnormal_feces_composition | 1.96222240 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.94752847 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.84671480 |
| 21 | MP0001764_abnormal_homeostasis | 1.70698936 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59284165 |
| 23 | MP0009697_abnormal_copulation | 1.55584074 |
| 24 | MP0005451_abnormal_body_composition | 1.44289271 |
| 25 | MP0003011_delayed_dark_adaptation | 1.40454428 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 1.35437320 |
| 27 | MP0002132_abnormal_respiratory_system | 1.34330223 |
| 28 | MP0003186_abnormal_redox_activity | 1.30248719 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.25815301 |
| 30 | MP0005670_abnormal_white_adipose | 1.17726797 |
| 31 | * MP0000598_abnormal_liver_morphology | 1.17435821 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.14296993 |
| 33 | MP0005647_abnormal_sex_gland | 1.12636541 |
| 34 | MP0002254_reproductive_system_inflammat | 1.05264336 |
| 35 | MP0000604_amyloidosis | 1.04373375 |
| 36 | MP0009764_decreased_sensitivity_to | 1.04143169 |
| 37 | MP0009763_increased_sensitivity_to | 1.02370375 |
| 38 | MP0010368_abnormal_lymphatic_system | 0.93523886 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 0.91441828 |
| 40 | MP0008469_abnormal_protein_level | 0.88160591 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 0.87940003 |
| 42 | * MP0009642_abnormal_blood_homeostasis | 0.86399705 |
| 43 | MP0005408_hypopigmentation | 0.83731239 |
| 44 | MP0002876_abnormal_thyroid_physiology | 0.83621832 |
| 45 | MP0002971_abnormal_brown_adipose | 0.83168568 |
| 46 | MP0002282_abnormal_trachea_morphology | 0.82839805 |
| 47 | MP0001915_intracranial_hemorrhage | 0.82805072 |
| 48 | MP0005084_abnormal_gallbladder_morpholo | 0.79100653 |
| 49 | * MP0002078_abnormal_glucose_homeostasis | 0.79078160 |
| 50 | MP0009765_abnormal_xenobiotic_induced | 0.78505896 |
| 51 | MP0005187_abnormal_penis_morphology | 0.76156979 |
| 52 | MP0005334_abnormal_fat_pad | 0.75668524 |
| 53 | MP0005535_abnormal_body_temperature | 0.75126870 |
| 54 | * MP0005376_homeostasis/metabolism_phenot | 0.73623243 |
| 55 | MP0005220_abnormal_exocrine_pancreas | 0.72681740 |
| 56 | MP0003690_abnormal_glial_cell | 0.70791997 |
| 57 | MP0001661_extended_life_span | 0.69692782 |
| 58 | MP0003879_abnormal_hair_cell | 0.68241827 |
| 59 | MP0001756_abnormal_urination | 0.63023654 |
| 60 | MP0003329_amyloid_beta_deposits | 0.62257087 |
| 61 | MP0009053_abnormal_anal_canal | 0.60983799 |
| 62 | MP0009785_altered_susceptibility_to | 0.60137598 |
| 63 | MP0002249_abnormal_larynx_morphology | 0.59922638 |
| 64 | MP0005666_abnormal_adipose_tissue | 0.59204527 |
| 65 | MP0005448_abnormal_energy_balance | 0.58829571 |
| 66 | MP0000639_abnormal_adrenal_gland | 0.58438669 |
| 67 | MP0006035_abnormal_mitochondrial_morpho | 0.56566374 |
| 68 | MP0005023_abnormal_wound_healing | 0.52679987 |
| 69 | MP0005464_abnormal_platelet_physiology | 0.51005776 |
| 70 | * MP0005266_abnormal_metabolism | 0.50970372 |
| 71 | MP0002837_dystrophic_cardiac_calcinosis | 0.49698024 |
| 72 | * MP0004130_abnormal_muscle_cell | 0.48671460 |
| 73 | MP0005395_other_phenotype | 0.47136335 |
| 74 | MP0001851_eye_inflammation | 0.46720314 |
| 75 | MP0008874_decreased_physiological_sensi | 0.46631663 |
| 76 | MP0002136_abnormal_kidney_physiology | 0.46329807 |
| 77 | MP0003638_abnormal_response/metabolism_ | 0.45890179 |
| 78 | MP0002822_catalepsy | 0.45524936 |
| 79 | MP0003724_increased_susceptibility_to | 0.44736580 |
| 80 | MP0002928_abnormal_bile_duct | 0.44549796 |
| 81 | MP0008873_increased_physiological_sensi | 0.44407744 |
| 82 | MP0003718_maternal_effect | 0.43609983 |
| 83 | MP0008872_abnormal_physiological_respon | 0.43550562 |
| 84 | MP0004782_abnormal_surfactant_physiolog | 0.43021003 |
| 85 | MP0009115_abnormal_fat_cell | 0.41018720 |
| 86 | MP0000467_abnormal_esophagus_morphology | 0.39976908 |
| 87 | * MP0003953_abnormal_hormone_level | 0.39957427 |
| 88 | MP0009672_abnormal_birth_weight | 0.39649641 |
| 89 | MP0001545_abnormal_hematopoietic_system | 0.39025675 |
| 90 | MP0005397_hematopoietic_system_phenotyp | 0.39025675 |
| 91 | MP0003436_decreased_susceptibility_to | 0.38906485 |
| 92 | MP0003075_altered_response_to | 0.38678475 |
| 93 | MP0002970_abnormal_white_adipose | 0.37635659 |
| 94 | MP0005248_abnormal_Harderian_gland | 0.36490746 |
| 95 | MP0005166_decreased_susceptibility_to | 0.35918013 |
| 96 | MP0000579_abnormal_nail_morphology | 0.34829432 |
| 97 | MP0004381_abnormal_hair_follicle | 0.34756545 |
| 98 | MP0002796_impaired_skin_barrier | 0.33189346 |
| 99 | MP0009384_cardiac_valve_regurgitation | 0.32878267 |
| 100 | MP0001853_heart_inflammation | 0.32627158 |
| 101 | MP0001243_abnormal_dermal_layer | 0.32371103 |
| 102 | MP0002168_other_aberrant_phenotype | 0.31682557 |
| 103 | MP0000249_abnormal_blood_vessel | 0.31051941 |
| 104 | MP0001881_abnormal_mammary_gland | 0.30535744 |
| 105 | MP0004883_abnormal_blood_vessel | 0.30119602 |
| 106 | MP0002090_abnormal_vision | 0.27890247 |
| 107 | MP0002060_abnormal_skin_morphology | 0.27618615 |
| 108 | MP0001845_abnormal_inflammatory_respons | 0.27025339 |
| 109 | MP0002128_abnormal_blood_circulation | 0.25754099 |
| 110 | * MP0000230_abnormal_systemic_arterial | 0.25448581 |
| 111 | MP0005164_abnormal_response_to | 0.24403986 |
| 112 | MP0005058_abnormal_lysosome_morphology | 0.23991320 |
| 113 | MP0006082_CNS_inflammation | 0.23380789 |
| 114 | MP0005375_adipose_tissue_phenotype | 0.19093962 |
| 115 | MP0003959_abnormal_lean_body | 0.18787388 |
| 116 | MP0001986_abnormal_taste_sensitivity | 0.17762486 |
| 117 | MP0005646_abnormal_pituitary_gland | 0.15955534 |
| 118 | MP0002295_abnormal_pulmonary_circulatio | 0.14746354 |
| 119 | MP0004272_abnormal_basement_membrane | 0.13904279 |
| 120 | MP0001944_abnormal_pancreas_morphology | 0.13623260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.40602516 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.36240011 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.18233410 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.64830294 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.52009998 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.31786743 |
| 7 | Xanthomatosis (HP:0000991) | 6.31641772 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.53899882 |
| 9 | Complement deficiency (HP:0004431) | 5.39881711 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.80082307 |
| 11 | Joint hemorrhage (HP:0005261) | 4.72793319 |
| 12 | Hyperammonemia (HP:0001987) | 4.70460897 |
| 13 | Epidermoid cyst (HP:0200040) | 4.60269586 |
| 14 | Hyperglycinemia (HP:0002154) | 4.40350474 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.40258657 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.36422249 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.34616807 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 4.27651035 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.22757437 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.22742548 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.19316660 |
| 22 | * Ketosis (HP:0001946) | 4.04844481 |
| 23 | Hyperglycinuria (HP:0003108) | 4.03870041 |
| 24 | Fat malabsorption (HP:0002630) | 4.01409829 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.99706505 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.99706505 |
| 27 | Abnormality of complement system (HP:0005339) | 3.93458030 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.90079859 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.86791941 |
| 30 | Nephritis (HP:0000123) | 3.84515365 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.72904304 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.66329742 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.63267301 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.49646534 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.46236436 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.36172785 |
| 37 | Abnormality of serum amino acid levels (HP:0003112) | 3.12386962 |
| 38 | Fair hair (HP:0002286) | 3.11199266 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.09123633 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.08283715 |
| 41 | Ketoacidosis (HP:0001993) | 3.06279073 |
| 42 | Steatorrhea (HP:0002570) | 3.02180098 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 3.01289707 |
| 44 | Hypochromic microcytic anemia (HP:0004840) | 2.97046936 |
| 45 | Purpura (HP:0000979) | 2.96293607 |
| 46 | Myocardial infarction (HP:0001658) | 2.92471658 |
| 47 | Spontaneous abortion (HP:0005268) | 2.87667207 |
| 48 | Skin nodule (HP:0200036) | 2.84527997 |
| 49 | Metabolic acidosis (HP:0001942) | 2.79697041 |
| 50 | Systemic lupus erythematosus (HP:0002725) | 2.74942821 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.69029602 |
| 52 | Increased mean platelet volume (HP:0011877) | 2.67626360 |
| 53 | Lethargy (HP:0001254) | 2.66312752 |
| 54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.66107940 |
| 55 | Dicarboxylic aciduria (HP:0003215) | 2.66107940 |
| 56 | Acanthocytosis (HP:0001927) | 2.61763924 |
| 57 | Abnormal gallbladder morphology (HP:0012437) | 2.51909709 |
| 58 | Cerebral edema (HP:0002181) | 2.51686227 |
| 59 | Vascular calcification (HP:0004934) | 2.49015582 |
| 60 | Spastic diplegia (HP:0001264) | 2.48979146 |
| 61 | Gout (HP:0001997) | 2.48833355 |
| 62 | Osteomalacia (HP:0002749) | 2.48678148 |
| 63 | Cholelithiasis (HP:0001081) | 2.45802582 |
| 64 | Hypoglycemic seizures (HP:0002173) | 2.45438337 |
| 65 | Abnormal platelet volume (HP:0011876) | 2.44568384 |
| 66 | Abnormal gallbladder physiology (HP:0012438) | 2.43285933 |
| 67 | Cholecystitis (HP:0001082) | 2.43285933 |
| 68 | Pulmonary embolism (HP:0002204) | 2.39114434 |
| 69 | Mitral stenosis (HP:0001718) | 2.38882271 |
| 70 | Irritability (HP:0000737) | 2.38792736 |
| 71 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.38405190 |
| 72 | Glomerulonephritis (HP:0000099) | 2.37922934 |
| 73 | Neonatal onset (HP:0003623) | 2.35242211 |
| 74 | Cardiovascular calcification (HP:0011915) | 2.21154748 |
| 75 | Amyloidosis (HP:0011034) | 2.21087852 |
| 76 | Pancreatitis (HP:0001733) | 2.19480944 |
| 77 | Brushfield spots (HP:0001088) | 2.19285219 |
| 78 | Epistaxis (HP:0000421) | 2.18986919 |
| 79 | Generalized hypopigmentation of hair (HP:0011358) | 2.18592103 |
| 80 | Esophageal varix (HP:0002040) | 2.18242505 |
| 81 | Enlarged kidneys (HP:0000105) | 2.14878868 |
| 82 | Sensorimotor neuropathy (HP:0007141) | 2.14026979 |
| 83 | Gingival bleeding (HP:0000225) | 2.13309144 |
| 84 | Generalized aminoaciduria (HP:0002909) | 2.12218496 |
| 85 | Malnutrition (HP:0004395) | 2.10972192 |
| 86 | Poikilocytosis (HP:0004447) | 2.10614527 |
| 87 | Menorrhagia (HP:0000132) | 2.10398002 |
| 88 | Reduced antithrombin III activity (HP:0001976) | 2.10272709 |
| 89 | Vomiting (HP:0002013) | 2.10218403 |
| 90 | Late onset (HP:0003584) | 2.06186482 |
| 91 | Abnormality of the gallbladder (HP:0005264) | 2.04028251 |
| 92 | Thrombophlebitis (HP:0004418) | 2.03245659 |
| 93 | Hemorrhage of the eye (HP:0011885) | 2.01166420 |
| 94 | Arthropathy (HP:0003040) | 2.00157983 |
| 95 | Opisthotonus (HP:0002179) | 1.99029790 |
| 96 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.98067081 |
| 97 | Hydroxyprolinuria (HP:0003080) | 1.94912768 |
| 98 | Abnormality of proline metabolism (HP:0010907) | 1.94912768 |
| 99 | Joint swelling (HP:0001386) | 1.93626443 |
| 100 | Abnormal cartilage morphology (HP:0002763) | 1.93026923 |
| 101 | Abnormality of the Achilles tendon (HP:0005109) | 1.92679875 |
| 102 | Blue irides (HP:0000635) | 1.92083242 |
| 103 | Rickets (HP:0002748) | 1.91565426 |
| 104 | Hyperphosphaturia (HP:0003109) | 1.91271099 |
| 105 | Renal cortical cysts (HP:0000803) | 1.91181523 |
| 106 | Abnormal platelet function (HP:0011869) | 1.89965010 |
| 107 | Impaired platelet aggregation (HP:0003540) | 1.89965010 |
| 108 | Abnormality of iron homeostasis (HP:0011031) | 1.86103924 |
| 109 | Elevated hepatic transaminases (HP:0002910) | 1.84489056 |
| 110 | Alkalosis (HP:0001948) | 1.83746248 |
| 111 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83329242 |
| 112 | Elevated alkaline phosphatase (HP:0003155) | 1.82923317 |
| 113 | Hypophosphatemic rickets (HP:0004912) | 1.82276269 |
| 114 | Abnormality of vitamin metabolism (HP:0100508) | 1.82211416 |
| 115 | Increased serum ferritin (HP:0003281) | 1.81017224 |
| 116 | Gangrene (HP:0100758) | 1.80135901 |
| 117 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79372244 |
| 118 | Status epilepticus (HP:0002133) | 1.78586649 |
| 119 | Glycosuria (HP:0003076) | 1.77003539 |
| 120 | Abnormality of urine glucose concentration (HP:0011016) | 1.77003539 |
| 121 | Reticulocytosis (HP:0001923) | 1.74790533 |
| 122 | Hypertriglyceridemia (HP:0002155) | 1.74500969 |
| 123 | Acute hepatic failure (HP:0006554) | 1.74041467 |
| 124 | Atrioventricular block (HP:0001678) | 1.73221248 |
| 125 | Cerebral palsy (HP:0100021) | 1.70537248 |
| 126 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.67280010 |
| 127 | Bifid scrotum (HP:0000048) | 1.54738233 |
| 128 | Prolonged bleeding time (HP:0003010) | 1.54151846 |
| 129 | Abnormal urine phosphate concentration (HP:0012599) | 1.49497571 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.34344278 |
| 2 | SIK1 | 4.59732099 |
| 3 | FGFR4 | 4.44204838 |
| 4 | ERN1 | 4.15896147 |
| 5 | INSRR | 3.11826541 |
| 6 | ERBB4 | 2.97956242 |
| 7 | TAOK3 | 2.87810880 |
| 8 | MAP2K4 | 2.36138386 |
| 9 | MYLK | 2.30937574 |
| 10 | PKN2 | 2.30783115 |
| 11 | MST1R | 2.16291008 |
| 12 | TRIB3 | 1.98453241 |
| 13 | MAPK11 | 1.96991549 |
| 14 | FLT3 | 1.94205809 |
| 15 | NTRK3 | 1.66529060 |
| 16 | LATS1 | 1.65827362 |
| 17 | TYK2 | 1.58872404 |
| 18 | PIK3CG | 1.58829627 |
| 19 | MAPKAPK3 | 1.57119667 |
| 20 | TNK2 | 1.56763817 |
| 21 | ABL2 | 1.50189623 |
| 22 | PRKG1 | 1.45868366 |
| 23 | FGFR2 | 1.42888888 |
| 24 | NEK9 | 1.39449855 |
| 25 | PTK6 | 1.36975462 |
| 26 | DAPK2 | 1.35739844 |
| 27 | FRK | 1.34898137 |
| 28 | CAMKK2 | 1.33120218 |
| 29 | KDR | 1.32149342 |
| 30 | MAP3K12 | 1.31238836 |
| 31 | PRPF4B | 1.28329777 |
| 32 | FER | 1.25602255 |
| 33 | JAK2 | 1.24528328 |
| 34 | PRKAA2 | 1.24516580 |
| 35 | ARAF | 1.22287090 |
| 36 | MAP3K7 | 1.17576061 |
| 37 | PINK1 | 1.16771086 |
| 38 | NLK | 1.15290277 |
| 39 | GRK6 | 1.10516548 |
| 40 | MAP2K3 | 1.08662885 |
| 41 | CAMK1D | 1.06489765 |
| 42 | ERBB2 | 1.03393183 |
| 43 | BRSK2 | 1.02916443 |
| 44 | JAK1 | 1.02345193 |
| 45 | MAPK4 | 1.01341434 |
| 46 | TBK1 | 1.01319603 |
| 47 | MAP3K10 | 0.95152828 |
| 48 | PRKACA | 0.94165982 |
| 49 | AKT3 | 0.92574128 |
| 50 | PRKCZ | 0.91863658 |
| 51 | MAP3K14 | 0.91714375 |
| 52 | STK38L | 0.88865738 |
| 53 | MET | 0.87086630 |
| 54 | MAP3K3 | 0.86035329 |
| 55 | CDK6 | 0.84715473 |
| 56 | ZAP70 | 0.82991637 |
| 57 | MAPK12 | 0.82288402 |
| 58 | EPHB1 | 0.79635939 |
| 59 | PRKACG | 0.79394435 |
| 60 | TIE1 | 0.79338717 |
| 61 | MAPK15 | 0.74849899 |
| 62 | MAP3K11 | 0.74724826 |
| 63 | EPHA3 | 0.73460180 |
| 64 | CSK | 0.71966328 |
| 65 | PRKAA1 | 0.70780625 |
| 66 | CAMK2G | 0.69221263 |
| 67 | BLK | 0.68551535 |
| 68 | GSK3A | 0.68139498 |
| 69 | MAP2K6 | 0.66639533 |
| 70 | RIPK1 | 0.65980459 |
| 71 | SGK3 | 0.65692211 |
| 72 | FGFR3 | 0.63209748 |
| 73 | DYRK1B | 0.63185289 |
| 74 | TGFBR2 | 0.62824249 |
| 75 | MUSK | 0.62577403 |
| 76 | MAP3K9 | 0.61762266 |
| 77 | PRKCB | 0.59003399 |
| 78 | IRAK3 | 0.58579735 |
| 79 | MAPK7 | 0.57281051 |
| 80 | PDPK1 | 0.56219931 |
| 81 | SGK1 | 0.55857560 |
| 82 | PRKACB | 0.55239310 |
| 83 | RPS6KA3 | 0.55225966 |
| 84 | CSF1R | 0.55147599 |
| 85 | PDK2 | 0.53140534 |
| 86 | STK16 | 0.52967603 |
| 87 | IKBKE | 0.51875970 |
| 88 | CSNK1D | 0.51667347 |
| 89 | PTK2 | 0.51222030 |
| 90 | TAOK2 | 0.49710266 |
| 91 | BCR | 0.49402015 |
| 92 | CAMK1G | 0.48945569 |
| 93 | PDK3 | 0.48860599 |
| 94 | PDK4 | 0.48860599 |
| 95 | EPHA4 | 0.47629422 |
| 96 | PRKCQ | 0.47493975 |
| 97 | ILK | 0.47009485 |
| 98 | TEC | 0.46679352 |
| 99 | SGK2 | 0.46330884 |
| 100 | RET | 0.46306608 |
| 101 | IGF1R | 0.46271591 |
| 102 | MAP3K5 | 0.45981681 |
| 103 | CSNK1G1 | 0.45233834 |
| 104 | MAP2K1 | 0.44875916 |
| 105 | CDK4 | 0.44734107 |
| 106 | SRC | 0.44428700 |
| 107 | PKN1 | 0.43342341 |
| 108 | MAP3K6 | 0.42614993 |
| 109 | CAMKK1 | 0.42613638 |
| 110 | MAP4K2 | 0.42317225 |
| 111 | AKT2 | 0.40542744 |
| 112 | MAP3K2 | 0.39197901 |
| 113 | GRK1 | 0.39136415 |
| 114 | EIF2AK1 | 0.38973076 |
| 115 | MTOR | 0.37957368 |
| 116 | CSNK1E | 0.37208496 |
| 117 | PDK1 | 0.37159910 |
| 118 | WNK3 | 0.36682945 |
| 119 | ICK | 0.36202455 |
| 120 | PRKCG | 0.35497652 |
| 121 | MAP3K13 | 0.34183572 |
| 122 | EGFR | 0.34123117 |
| 123 | SGK494 | 0.34005769 |
| 124 | SGK223 | 0.34005769 |
| 125 | CAMK4 | 0.28273538 |
| 126 | LATS2 | 0.27475561 |
| 127 | PBK | 0.26131877 |
| 128 | IRAK2 | 0.25644331 |
| 129 | IRAK1 | 0.25628876 |
| 130 | PRKCA | 0.25411216 |
| 131 | PIK3CA | 0.24369163 |
| 132 | CSNK1G2 | 0.23193217 |
| 133 | ABL1 | 0.22150497 |
| 134 | MAP3K1 | 0.21726410 |
| 135 | BMX | 0.19423691 |
| 136 | MAPK3 | 0.18810057 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.50134761 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.60791539 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.43268783 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31519019 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.08328516 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.71780990 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69436759 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.69280174 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62468376 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56128318 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.52812191 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.43866046 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24774647 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.16559973 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09420330 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.08691203 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.01544157 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.95155497 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92369399 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89869370 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.88800467 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.88011402 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.86632400 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.83343911 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.74022184 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73870066 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73265155 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.70867122 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.68387994 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66740468 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.58992511 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.58224484 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58136421 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55383644 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48354688 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.47275230 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43103610 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.42928992 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35753828 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31229886 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.29724727 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22851729 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.20191465 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17093667 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16687054 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16159510 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14113740 |
| 48 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13017954 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02091493 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98981986 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.98050257 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97783842 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95172056 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.93527343 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91235111 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87336199 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86277032 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.82578642 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.82198444 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72530568 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72060371 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.71444907 |
| 63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62706965 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62575500 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.61203259 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58594607 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46173910 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.36169337 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34758884 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.32179648 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26915200 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25666843 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25275447 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24654942 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23009744 |
| 76 | * Insulin resistance_Homo sapiens_hsa04931 | 0.19668609 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17932570 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17469578 |
| 79 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06436347 |
| 80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.05184209 |
| 81 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01342211 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.2746935 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2644594 |
| 84 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.2632199 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2599344 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2565463 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | -0.2348364 |
| 88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2222045 |
| 89 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2193794 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2117658 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2049810 |
| 92 | Other glycan degradation_Homo sapiens_hsa00511 | -0.2013039 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1960238 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1916832 |
| 95 | Platelet activation_Homo sapiens_hsa04611 | -0.1884361 |
| 96 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1831828 |
| 97 | Hepatitis C_Homo sapiens_hsa05160 | -0.1810753 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1569452 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1543159 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1500706 |
| 101 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1485095 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1450647 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1400080 |
| 104 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1339044 |
| 105 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1333722 |
| 106 | * Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1244332 |
| 107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1066209 |
| 108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0894651 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | -0.0727138 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0660703 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0122857 |

